menu
    • menu

    Company profile for Lipella Pharmaceuticals

    NEW Drugs in Dev: 6
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Lipella is a privately-held biotechnology company with a focus on supportive care to cancer survivors who acquire hemorrhagic cystitis, as well as improved surveillance and imaging of patients with a history of transitional cell carcinoma. Our lead product, LP-10 (liposomal tacrolimus) is in clinical development for the treatment of hemorrhagic cystitis. We maintain a pipeline of additional product candidates consistent with ...
    Lipella is a privately-held biotechnology company with a focus on supportive care to cancer survivors who acquire hemorrhagic cystitis, as well as improved surveillance and imaging of patients with a history of transitional cell carcinoma. Our lead product, LP-10 (liposomal tacrolimus) is in clinical development for the treatment of hemorrhagic cystitis. We maintain a pipeline of additional product candidates consistent with our strategy of developing proprietary 505(b)(2) assets that address highly-morbid indications where no adequate treatment(s) exists. A partial list of these assets is as follows.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lipella PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    7800 Susquehanna St, Suite 505 Pittsburgh, PA 15208
    Telephone
    Telephone
    1-412-894-1853
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://lipella.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/lipella-pharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ICMD China

    ICMD China

    Not Confirmed

    envelop Contact Supplier

    ICMD China

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lipella Goes Bankrupt, Ending Mouth Inflammation Drug Ambitions
    Lipella Goes Bankrupt, Ending Mouth Inflammation Drug Ambitions

    31 Mar 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/lipella-files-bankruptcy-ending-dream-developing-mouth-inflammation-drug

    FIERCE BIOTECH
    31 Mar 2026
    Share Share
    Lipella Pharma Reports Successful Phase 2a Results for LP-10
    Lipella Pharma Reports Successful Phase 2a Results for LP-10

    18 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/18/3152357/0/en/Lipella-Pharmaceuticals-Announces-Positive-Final-Results-from-Phase-2a-Study-of-LP-10-in-Oral-Lichen-Planus.html

    GLOBENEWSWIRE
    18 Sep 2025
    Share Share
    Lipella to Present Final Phase 2a Results at Zacks SCR Forum
    Lipella to Present Final Phase 2a Results at Zacks SCR Forum

    15 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lipella-pharmaceuticals-to-present-at-zacks-scr-life-sciences-virtual-investor-forum-and-report-final-phase-2a-results-in-oral-lichen-planus-302555853.html

    PR NEWSWIRE
    15 Sep 2025
    Share Share
    Lipella CEO Issues Letter to Shareholders After Nasdaq Exit
    Lipella CEO Issues Letter to Shareholders After Nasdaq Exit

    25 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/25/3105404/0/en/Lipella-Pharmaceuticals-Issues-Letter-from-the-CEO-to-Stockholders-Following-Nasdaq-Delisting.html

    GLOBENEWSWIRE
    25 Jun 2025
    Share Share
    Lipella Pharmaceuticals Delists from Nasdaq Market
    Lipella Pharmaceuticals Delists from Nasdaq Market

    20 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/20/3102906/0/en/Lipella-Pharmaceuticals-Announces-Delisting-from-Nasdaq-Capital-Market.html

    GLOBENEWSWIRE
    20 Jun 2025
    Share Share
    Lipella Pharmaceuticals Announces U.S. Patent for Diagnostic Tech
    Lipella Pharmaceuticals Announces U.S. Patent for Diagnostic Tech

    17 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/17/3100642/0/en/Lipella-Pharmaceuticals-Announces-U-S-Patent-Issuance-for-Diagnostic-Technology.html

    GLOBENEWSWIRE
    17 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search